RT Journal Article
SR Electronic
T1 A Bayesian Susceptible-Infectious-Hospitalized-Ventilated-Recovered Model to Predict Demand for COVID-19 Inpatient Care in a Large Healthcare System
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.01.20241984
DO 10.1101/2020.12.01.20241984
A1 Self, Stella Coker Watson
A1 Huang, Rongjie
A1 Amin, Shrujan
A1 Ewing, Joseph
A1 Rudisill, Caroline
A1 McLain, Alexander C.
YR 2020
UL http://medrxiv.org/content/early/2020/12/03/2020.12.01.20241984.abstract
AB The COVID-19 pandemic strained healthcare systems in many parts of the United States. During the early months of the pandemic, there was substantial uncertainty about whether the large number of COVID-19 patients requiring hospitalization would exceed healthcare system capacity. This uncertainty created an urgent need for accurate predictions about the number of COVID-19 patients requiring inpatient and ventilator care at the local level. In this work, we develop a Bayesian Susceptible-Infectious-Hospitalized-Ventilated-Recovered (SIHVR) model to predict the burden of COVID-19 at the healthcare system level. The Bayesian SIHVR model provides daily estimates of the number of new COVID-19 patients admitted to inpatient care, the total number of non-ventilated COVID-19 inpatients, and the total number of ventilated COVID-19 patients at the healthcare system level. The model also incorporates county-level data on the number of reported COVID-19 cases, and county-level social distancing metrics, making it locally customizable. The uncertainty in model predictions is quantified with 95% credible intervals. The Bayesian SIHVR model is validated with an extensive simulation study, and then applied to data from two regional healthcare systems in South Carolina. This model can be adapted for other healthcare systems to estimate local resource needs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this manuscript was funded through a Health Sciences Center at Prisma Health Seed Grant Award.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the IRB at Prisma Health Upstate.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe USDS data is publicly available on the Unacast webpage at https://www.unacast.com/covid19/social-distancing-scoreboard. The county and state level reported case incidence data, and statewide hospital census data is publicly available on the SCDHEC webpage at https://scdhec.gov/covid19/south-carolina-county-level-data-covid-19. Code which implements the model described in the manuscript may be found at https://github.com/scwatson812/BayesianSIHVRModel